Critical Care Nursing Diagnoses for NSTEMI: A Comprehensive Guide

Myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow to the heart muscle is severely reduced or blocked, leading to myocardial ischemia. This lack of blood supply starves the heart muscle of oxygen and nutrients, potentially causing irreversible damage. While ST-elevation myocardial infarction (STEMI) is characterized by a complete blockage and specific ECG changes, a non-ST-elevation myocardial infarction (NSTEMI) involves a partial blockage of a coronary artery. NSTEMI, while sometimes less immediately obvious on an ECG, is a serious condition requiring prompt recognition and intensive critical care nursing.

In the critical care setting, patients experiencing NSTEMI present unique challenges. These patients require continuous monitoring, advanced interventions, and meticulous nursing care to stabilize their condition, prevent complications, and improve outcomes. This article delves into the critical care nursing diagnoses pertinent to NSTEMI, providing a comprehensive guide for nurses working in intensive care and cardiac units.

Understanding NSTEMI vs. STEMI in Critical Care

While both STEMI and NSTEMI are types of heart attacks, understanding their differences is crucial for guiding critical care nursing interventions. STEMI involves a complete occlusion of a coronary artery, typically due to a thrombus formation over a ruptured atherosclerotic plaque. This complete blockage results in significant ST-segment elevation on an electrocardiogram (ECG), indicating a large area of myocardial injury. Immediate reperfusion therapy, such as percutaneous coronary intervention (PCI) or fibrinolysis, is the priority in STEMI to restore blood flow and salvage heart muscle.

NSTEMI, in contrast, is characterized by a partial or intermittent occlusion of a coronary artery. This may be due to a thrombus that doesn’t completely block the artery, severe coronary artery narrowing, or even coronary vasospasm. ECG changes in NSTEMI are less pronounced than in STEMI and may include ST-segment depression, T-wave inversion, or no significant ST-segment elevation. However, critically, patients with NSTEMI still experience myocardial damage, evidenced by elevated cardiac biomarkers like troponin. In critical care, differentiating between STEMI and NSTEMI guides the urgency and type of interventions, but both require vigilant monitoring and aggressive management to prevent further myocardial damage and complications.

Critical Care Nursing Assessment for NSTEMI

The cornerstone of effective critical care nursing for NSTEMI lies in comprehensive and continuous assessment. Upon admission to the critical care unit, a thorough baseline assessment is essential, followed by ongoing monitoring to detect subtle changes and guide interventions.

Initial Assessment in Critical Care

1. Rapid ABC Assessment: As with any critical patient, prioritize Airway, Breathing, and Circulation. Ensure a patent airway, assess respiratory rate, depth, and effort, and evaluate circulatory status by checking heart rate, blood pressure, peripheral pulses, and capillary refill.

2. Cardiac Monitoring and ECG: Continuous cardiac monitoring is mandatory. Analyze the ECG for any ST-segment changes, T-wave abnormalities, arrhythmias, and heart rate patterns. Serial ECGs may be necessary to detect evolving changes.

3. Hemodynamic Monitoring: In critical care, invasive hemodynamic monitoring may be indicated, especially in patients with hemodynamic instability or significant comorbidities. This may include:

   • Arterial Line: For continuous blood pressure monitoring and frequent arterial blood gas (ABG) sampling.
   • Central Venous Catheter (CVC): To measure central venous pressure (CVP), guide fluid management, and administer vasoactive medications.
   • Pulmonary Artery Catheter (Swan-Ganz): In complex cases, a pulmonary artery catheter may be used to assess pulmonary artery pressure, pulmonary capillary wedge pressure (PCWP), and cardiac output, providing a comprehensive hemodynamic profile.

4. Pain Assessment: Chest pain is the hallmark symptom of MI. However, in critically ill patients, pain presentation can be atypical or difficult to assess, particularly in those who are intubated or have altered mental status. Utilize pain scales appropriate for the patient’s condition (e.g., numerical rating scale for alert patients, behavioral pain scales for nonverbal patients). Assess pain characteristics:

   • Location: Chest, radiating to jaw, arm, back, or epigastric area.
   • Character: Crushing, squeezing, tightness, burning.
   • Intensity: Use a pain scale (0-10).
   • Timing: Onset, duration, aggravating and relieving factors.

5. Respiratory Assessment: Assess for signs of heart failure, a potential complication of NSTEMI. This includes:

   • Dyspnea: Shortness of breath, both at rest and with exertion.
   • Orthopnea: Difficulty breathing when lying flat.
   • Paroxysmal Nocturnal Dyspnea (PND): Sudden onset of shortness of breath at night.
   • Crackles or Wheezes: Auscultate lung sounds for adventitious breath sounds indicative of pulmonary edema.

6. Fluid Status Assessment: Monitor for signs of fluid overload or dehydration. Assess:

   • Intake and Output: Strict monitoring of fluid balance.
   • Edema: Peripheral edema (pedal, sacral), pulmonary edema.
   • Jugular Venous Distention (JVD): Elevated JVP suggests fluid overload.
   • Weight: Daily weights to track fluid changes.

7. Neurological Assessment: Assess level of consciousness, orientation, and neurological deficits. Changes in mental status can indicate decreased cerebral perfusion secondary to reduced cardiac output.

8. Gastrointestinal Assessment: Nausea and vomiting are common symptoms. Assess bowel sounds and abdominal distention.

9. Skin Assessment: Evaluate skin color, temperature, and moisture. Cool, clammy, pale, or cyanotic skin can indicate poor peripheral perfusion.

10. Psychosocial Assessment: Critical illness and the threat of a heart attack induce significant anxiety and fear. Assess the patient’s emotional state, coping mechanisms, and support system. Consider the anxiety of family members as well.

Ongoing Monitoring in Critical Care

Continuous monitoring is paramount in the critical care management of NSTEMI. This includes:

• Continuous ECG monitoring: For early detection of arrhythmias or ST-segment changes.
• Frequent vital signs monitoring: Blood pressure, heart rate, respiratory rate, oxygen saturation.
• Hemodynamic monitoring (if indicated): Continuous arterial blood pressure, CVP, PA pressures.
• Hourly urine output: To assess renal perfusion and fluid balance.
• Regular pain assessment: To evaluate pain control and adjust analgesia as needed.
• Respiratory assessment: Monitor for worsening respiratory distress or signs of pulmonary edema.
• Neurological status checks: To detect changes in level of consciousness or neurological deficits.
• Cardiac biomarker trends: Serial troponin levels to assess the extent of myocardial damage and monitor for ongoing ischemia.
• Electrolyte monitoring: Potassium, magnesium, and calcium imbalances can exacerbate arrhythmias.

Key Critical Care Nursing Diagnoses for NSTEMI

Based on the comprehensive assessment, several critical care nursing diagnoses are commonly identified in patients with NSTEMI. These diagnoses guide the plan of care and prioritize nursing interventions.

1. Decreased Cardiac Output

Nursing Diagnosis: Decreased Cardiac Output related to altered myocardial contractility and changes in heart rate and rhythm secondary to NSTEMI, as evidenced by hypotension, tachycardia, dysrhythmias, decreased urine output, cool and clammy skin, and altered mental status.

Critical Care Focus: In critical care, decreased cardiac output in NSTEMI can rapidly lead to cardiogenic shock, a life-threatening condition. Interventions are aimed at optimizing preload, afterload, and contractility.

Critical Care Interventions:

• Hemodynamic Monitoring: Continuously monitor arterial blood pressure, CVP, and potentially PA pressures to guide therapy.
• Fluid Management: Administer intravenous fluids cautiously to optimize preload, guided by CVP and PCWP measurements. Avoid fluid overload, which can worsen heart failure.
• Vasoactive Medications:
  • Inotropes (e.g., Dobutamine, Milrinone): To enhance myocardial contractility and improve cardiac output. These are often titrated based on hemodynamic response.
  • Vasopressors (e.g., Norepinephrine, Dopamine): To support blood pressure in hypotensive patients. Vasopressors are crucial in managing cardiogenic shock.
  • Vasodilators (e.g., Nitroglycerin, Nitroprusside): To reduce afterload and improve myocardial oxygen supply. These are used cautiously in hypotensive patients.
• Oxygen Therapy: Maintain adequate oxygenation to reduce myocardial ischemia. May require supplemental oxygen via nasal cannula, face mask, or mechanical ventilation in severe cases.
• Mechanical Circulatory Support: In refractory cardiogenic shock, consider advanced therapies such as:
  • Intra-Aortic Balloon Pump (IABP): To reduce afterload and improve coronary artery perfusion.
  • Percutaneous Ventricular Assist Devices (p-VADs) (e.g., Impella, TandemHeart): To provide temporary mechanical circulatory support.
  • Extracorporeal Membrane Oxygenation (ECMO): In the most severe cases of cardiogenic shock unresponsive to other therapies, ECMO may be considered as a bridge to recovery or further interventions.
• Arrhythmia Management: Promptly identify and treat life-threatening arrhythmias (e.g., ventricular tachycardia, ventricular fibrillation, bradycardia). Administer antiarrhythmic medications as ordered and prepare for cardioversion or pacing if needed.

2. Ineffective Tissue Perfusion (Cardiopulmonary)

Nursing Diagnosis: Ineffective Tissue Perfusion (Cardiopulmonary) related to interruption of arterial blood flow secondary to coronary artery occlusion in NSTEMI, as evidenced by chest pain, ECG changes, elevated cardiac biomarkers, dyspnea, and changes in level of consciousness.

Critical Care Focus: Maintaining adequate cardiopulmonary tissue perfusion is paramount to minimize myocardial damage and prevent end-organ dysfunction in NSTEMI.

Critical Care Interventions:

• Reperfusion Therapy: While NSTEMI is a partial occlusion, timely reperfusion strategies are still crucial. Collaborate with the cardiology team regarding:
  • Percutaneous Coronary Intervention (PCI): Prepare the patient for urgent or early PCI based on risk stratification and clinical status. This is the definitive treatment to restore blood flow.
  • Pharmacological Management:
    • Antiplatelet Therapy (e.g., Aspirin, Clopidogrel, Ticagrelor): Administer dual antiplatelet therapy (DAPT) as ordered to prevent thrombus propagation.
    • Anticoagulation (e.g., Heparin, Enoxaparin, Bivalirudin): Administer anticoagulants to prevent further clot formation.
    • Nitrates (e.g., Nitroglycerin): To promote coronary vasodilation and improve blood flow.
    • Beta-blockers: To reduce myocardial oxygen demand by decreasing heart rate and contractility. Use cautiously in patients with heart failure or hypotension.
    • ACE Inhibitors/ARBs: For long-term management to reduce afterload and prevent cardiac remodeling, especially in patients with heart failure or hypertension.
• Oxygen Therapy: Maintain adequate oxygenation to ensure sufficient oxygen delivery to the myocardium and other vital organs.
• Positioning: Elevate the head of the bed to improve ventilation and reduce preload, unless contraindicated by hypotension.
• Monitoring for Complications: Closely monitor for signs of:
  • Heart Failure: Pulmonary edema, worsening dyspnea, decreased oxygen saturation.
  • Arrhythmias: Life-threatening arrhythmias require immediate intervention.
  • Cardiogenic Shock: Hypotension, decreased cardiac output, end-organ hypoperfusion.

3. Acute Pain

Nursing Diagnosis: Acute Pain related to myocardial ischemia secondary to NSTEMI, as evidenced by patient report of chest pain, restlessness, guarding behavior, diaphoresis, and changes in vital signs.

Critical Care Focus: Pain management in critical care for NSTEMI aims to provide rapid and effective pain relief while minimizing hemodynamic instability and respiratory depression.

Critical Care Interventions:

• Pain Assessment: Frequently assess pain using appropriate pain scales, even in nonverbal patients. Document pain characteristics and response to interventions.
• Pharmacological Pain Management:
  • Opioid Analgesics (e.g., Morphine, Fentanyl): Intravenous opioids are often the first-line treatment for severe MI pain in critical care. Morphine also has venodilating effects, which can reduce preload. Fentanyl may be preferred for patients with hypotension due to its less pronounced hemodynamic effects. Administer cautiously and monitor for respiratory depression and hypotension.
  • Nitroglycerin: Continue nitroglycerin administration as ordered to relieve ischemic pain by promoting coronary vasodilation.
  • Non-Pharmacological Measures: Complementary therapies such as relaxation techniques, distraction, and positioning may be used in conjunction with pharmacological interventions.
• Titration and Monitoring: Titrate pain medications to achieve adequate pain relief while closely monitoring vital signs, respiratory status, and level of consciousness.
• Patient Education: Educate the patient and family about the importance of pain management and the plan of care.

4. Anxiety

Nursing Diagnosis: Anxiety related to threat to health status, fear of death, and critical care environment secondary to NSTEMI, as evidenced by restlessness, verbalization of fear, increased heart rate and respiratory rate, and apprehension.

Critical Care Focus: Severe anxiety can exacerbate myocardial ischemia and increase cardiac workload. Critical care nursing interventions focus on reducing anxiety and promoting psychological comfort in a stressful environment.

Critical Care Interventions:

• Therapeutic Communication: Establish a calm and reassuring presence. Encourage the patient to verbalize fears and concerns. Provide honest and accurate information about their condition and treatment plan.
• Environmental Management: Minimize environmental stressors in the critical care unit (e.g., noise, excessive lighting). Promote a quiet and restful environment when possible.
• Pharmacological Anxiolytics: In severe anxiety, consider short-acting benzodiazepines (e.g., Midazolam, Lorazepam) as ordered, especially if anxiety is contributing to hemodynamic instability or respiratory distress. Use cautiously and monitor for respiratory depression.
• Non-Pharmacological Interventions:
  • Relaxation Techniques: Guided imagery, deep breathing exercises, and music therapy can help reduce anxiety.
  • Family Support: Involve family members in providing emotional support and reassurance. Facilitate communication between the patient, family, and medical team.
  • Spiritual Support: Offer access to spiritual care providers if desired by the patient or family.
• Patient Education: Educate the patient and family about anxiety management strategies and coping mechanisms.

5. Risk for Unstable Blood Pressure

Nursing Diagnosis: Risk for Unstable Blood Pressure related to myocardial ischemia, altered cardiac output, and vasoactive medication administration secondary to NSTEMI.

Critical Care Focus: Blood pressure instability, both hypotension and hypertension, can be detrimental in NSTEMI. Hypotension compromises coronary perfusion, while hypertension increases myocardial workload. Critical care management aims to maintain blood pressure within a target range that optimizes myocardial oxygen supply and demand.

Critical Care Interventions:

• Continuous Hemodynamic Monitoring: Arterial line for continuous blood pressure monitoring is crucial.
• Pharmacological Blood Pressure Management:
  • Hypotension Management:
    • Fluid Boluses: If hypotension is due to hypovolemia, administer intravenous fluid boluses cautiously, guided by CVP and PCWP.
    • Vasopressors (e.g., Norepinephrine, Dopamine): For persistent hypotension unresponsive to fluid resuscitation. Titrate vasopressors to maintain blood pressure within the target range.
    • Inotropes (e.g., Dobutamine): If hypotension is associated with decreased cardiac output, inotropes may be needed to improve contractility and blood pressure.
  • Hypertension Management:
    • Vasodilators (e.g., Nitroglycerin, Nitroprusside): To reduce afterload and blood pressure. Nitroglycerin is often used for both pain relief and blood pressure control.
    • Beta-blockers: Help lower blood pressure and heart rate, reducing myocardial oxygen demand.
    • ACE Inhibitors/ARBs: For long-term blood pressure control and cardioprotection.
• Frequent Blood Pressure Monitoring: Monitor blood pressure frequently, especially during vasoactive medication titration and after interventions.
• Identify and Treat Underlying Causes: Address underlying causes of blood pressure instability, such as arrhythmias, hypovolemia, or pain.
• Patient Positioning: Trendelenburg position may be used temporarily in hypotensive patients to improve venous return, but use cautiously and monitor respiratory status.

Critical Care Nursing Interventions: A Summary

Critical care nursing for NSTEMI encompasses a multifaceted approach. Key interventions include:

• Rapid Recognition and Assessment: Promptly identify patients with suspected NSTEMI and perform a thorough assessment.
• Continuous Monitoring: Utilize cardiac and hemodynamic monitoring to detect subtle changes and guide interventions.
• Reperfusion Strategies: Facilitate timely PCI or pharmacologic reperfusion as indicated.
• Pharmacological Management: Administer antiplatelets, anticoagulants, nitrates, beta-blockers, ACE inhibitors/ARBs, and vasoactive medications as ordered.
• Pain and Anxiety Management: Provide effective pain relief and address anxiety to reduce myocardial workload and improve patient comfort.
• Hemodynamic Support: Optimize preload, afterload, and contractility through fluid management and vasoactive medications. Consider mechanical circulatory support in severe cases.
• Oxygen Therapy: Maintain adequate oxygenation to reduce myocardial ischemia.
• Education and Support: Educate patients and families about NSTEMI, treatment plan, and long-term management. Provide emotional and psychological support.

Cardiac Rehabilitation in Critical Care

While formal cardiac rehabilitation programs typically begin after hospital discharge, the foundation for rehabilitation starts in the critical care unit. Early mobilization, when appropriate, can prevent complications of immobility. Patient and family education regarding lifestyle modifications, medication adherence, and risk factor management should commence in the critical care setting. Discharge planning should begin early to ensure a smooth transition to home or a rehabilitation facility, with continued cardiac rehabilitation follow-up.

Conclusion

Critical care nursing diagnoses for NSTEMI are essential for guiding comprehensive and individualized patient care. By focusing on decreased cardiac output, ineffective tissue perfusion, acute pain, anxiety, and risk for unstable blood pressure, critical care nurses can provide targeted interventions to stabilize patients, minimize myocardial damage, prevent complications, and improve outcomes for individuals experiencing NSTEMI. Vigilant assessment, continuous monitoring, and collaborative care are paramount in the critical care management of this complex cardiac condition.

References

1. American College of Cardiology. (2015, September 21). Is sexual activity safe after MI? Retrieved March 2023, from https://www.acc.org/latest-in-cardiology/articles/2015/09/21/16/25/is-sexual-activity-safe-after-mi
2. Cleveland Clinic. (2021, December 28). NSTEMI: Causes, symptoms, diagnosis, treatment & outlook. Retrieved March 2023, from https://my.clevelandclinic.org/health/diseases/22233-nstemi-heart-attack#diagnosis-and-tests
3. Cleveland Clinic. (2022, October 30). Heart attack: What is it, causes, symptoms & treatment. Retrieved March 2023, from https://my.clevelandclinic.org/health/diseases/16818-heart-attack-myocardial-infarction#diagnosis-and-tests
4. Dewit, S. C., Stromberg, H., & Dallred, C. (2017). Care of Patients With Diabetes and Hypoglycemia. In Medical-surgical nursing: Concepts & practice (3rd ed., pp. 811-817). Elsevier Health Sciences.
5. Doenges, M. E., Moorhouse, M. F., & Murr, A. C. (2019). Nurse’s pocket guide: Diagnoses, interventions, and rationales (15th ed.). F A Davis Company.
6. Harding, M. M., Kwong, J., Roberts, D., Reinisch, C., & Hagler, D. (2020). Lewis’s medical-surgical nursing – 2-Volume set: Assessment and management of clinical problems (11th ed., pp. 2697-2729). Mosby.
7. Hinkle, J. L., & Cheever, K. H. (2018). Management of Patients With Coronary Vascular Disorders. In Brunner and Suddarth’s textbook of medical-surgical nursing (13th ed., pp. 1567-1575). Wolters Kluwer India Pvt.
8. Ignatavicius, MS, RN, CNE, ANEF, D. D., Workman, PhD, RN, FAAN, M. L., Rebar, PhD, MBA, RN, COI, C. R., & Heimgartner, MSN, RN, COI, N. M. (2018). Medical-Surgical Nursing: Concepts for Interprofessional Collaborative Care (9th ed., pp. 1386-1388). Elsevier.
9. Johns Hopkins Medicine. (n.d.). Heart attack. Johns Hopkins Medicine, based in Baltimore, Maryland. Retrieved February 2023, from https://www.hopkinsmedicine.org/health/conditions-and-diseases/heart-attack
10. Mayo Clinic. (2022, May 21). Heart attack – Symptoms and causes. Retrieved March 2023, from https://www.mayoclinic.org/diseases-conditions/heart-attack/symptoms-causes/syc-20373106
11. National Center for Biotechnology Information. (2022, August 8). Myocardial infarction – StatPearls – NCBI bookshelf. Retrieved March 2023, from https://www.ncbi.nlm.nih.gov/books/NBK537076/
12. Ojha, N., & Dhamoon, A. S. (2022, May 11). Myocardial infarction – StatPearls – NCBI bookshelf. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK537076/
13. Silvestri, L. A., Silvestri, A. E., & Grimm, J. (2022). Saunders comprehensive review for the NCLEX-RN examination (9th ed.). Elsevier Inc.
14. Winchester Hospital. (n.d.). Drugs that may lead to heart damage. Retrieved March 2023, from https://www.winchesterhospital.org/health-library/article?id=31675